The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Thoas Fioretos

Thoas Fioretos

Research team manager

Thoas Fioretos

The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI Therapy Data From a Randomized Phase II NordCML006 Study

Author

  • Satu Mustjoki
  • Johan Richter
  • Gisela Barbany
  • Ingunn Dybedal
  • Thoas Fioretos
  • Tobias Gedde Dahl
  • Bjorn T. Gjertsen
  • Randi Hovland
  • Sari Jalkanen
  • Dag Josefsen
  • Perttu Koskenvesa
  • Carin Lassen
  • Kirsi Latvala
  • Waleed Majeed
  • Claes Malm
  • Berit Markevarn
  • Ali Moshfegh
  • Lotta Ohm
  • Tor Olofsson
  • Ulla Olsson Stromberg
  • Katrin Rapakko
  • Kari Remes
  • Jesper Stentoft
  • Leif Stenke
  • Merja Suominen
  • Sara Thunberg
  • Ole Weiss Bjerrum
  • Bengt Simonsson
  • Kimmo Porkka
  • Henrik Hjorth Hansen
Show all

Department/s

  • Division of Molecular Medicine and Gene Therapy
  • Division of Clinical Genetics
  • Division of Hematology and Clinical Immunology
  • StemTherapy: National Initiative on Stem Cells for Regenerative Therapy

Publishing year

2010

Language

English

Pages

291-292

Publication/Series

Blood

Volume

116

Issue

21

Document type

Conference paper: abstract

Publisher

American Society of Hematology

Topic

  • Hematology

Conference name

52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Conference date

2010-12-04 - 2010-12-07

Status

Published

ISBN/ISSN/Other

  • ISSN: 1528-0020